Manipal HealthMap targets 200 centres by 2027, acquires iGenetic    Illustrative image – not actual.

Manipal HealthMap has fully acquired iGenetic Diagnostics, and with this acquisition, the diagnostic services provider plans to strengthen its presence in key markets, including Maharashtra, Madhya Pradesh, and Karnataka.

Following the merger, the company will steer its expansion efforts as it is targeting to establish over 200 centres by 2027, further expanding into metro cities as well as tier-I, tier-II, and tier-III cities through public-private partnership (PPP), business-to-business (B2B), business-to-consumer (B2C), contract research organisation (CRO), and institutional clients.

The move is In line with the company’s expansion plan, it looks to provide quality yet affordable pathological services with faster turnaround time, creating a more integrated and efficient diagnostic services network. The merger has received approval from the National Company Law Tribunal (NCLT). 

The company, controlled by Manipal Group and Morgan Stanley, operates in 17 states with a robust network of 55 radiology centres. Additionally, its pathology division in  35 locations provides specialised testing protocols across multiple areas of diagnostics.

← All latest storiesBack to top →